Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Leukemia Inhibitory Factor Enhances Survival of Cardiomyocytes and Induces Regeneration of Myocardium After Myocardial Infarction

Leukemia Inhibitory Factor Enhances Survival of Cardiomyocytes and Induces Regeneration of... Leukemia Inhibitory Factor Enhances Survival of Cardiomyocytes and Induces Regeneration of Myocardium After Myocardial Infarction Yunzeng Zou, MD, PhD; Hiroyuki Takano, MD, PhD; Miho Mizukami, MD; Hiroshi Akazawa, MD; Yingjie Qin, MD; Haruhiro Toko, MD; Masaya Sakamoto, MD; Tohru Minamino, MD, PhD; Toshio Nagai, MD, PhD; Issei Komuro, MD, PhD Background—Myocardial infarction (MI) is a leading cause of cardiac morbidity and mortality in many countries; however, the treatment of MI is still limited. Methods and Results—We demonstrate a novel gene therapy for MI using leukemia inhibitory factor (LIF) cDNA. We injected LIF plasmid DNA into the thigh muscle of mice immediately after inducing MI. Intramuscular injection of LIF cDNA resulted in a marked increase in circulating LIF protein concentrations. Two weeks later, left ventricular remodeling, such as infarct extent and myocardial fibrosis, was markedly attenuated in the LIF cDNA–injected mice compared with vehicle-injected mice. More myocardium was preserved and cardiac function was better in the LIF-treated mice than in the vehicle-injected mice. Injection of LIF cDNA not only prevented the death of cardiomyocytes in the ischemic area but also induced neovascularization in the myocardium. Furthermore, LIF cDNA injection increased the number of cardiomyocytes in cell cycle and enhanced mobilization http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Circulation Wolters Kluwer Health

Leukemia Inhibitory Factor Enhances Survival of Cardiomyocytes and Induces Regeneration of Myocardium After Myocardial Infarction

Komuro, Issei
Circulation , Volume 108 (6) – Aug 1, 2003
Download PDF
6 pages

Loading next page...
 
/lp/wolters-kluwer-health/leukemia-inhibitory-factor-enhances-survival-of-cardiomyocytes-and-3r4ttDPxx8

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0009-7322
eISSN
1524-4539
DOI
10.1161/01.CIR.0000081773.76337.44
pmid
12860906
Publisher site
See Article on Publisher Site

Abstract

Leukemia Inhibitory Factor Enhances Survival of Cardiomyocytes and Induces Regeneration of Myocardium After Myocardial Infarction Yunzeng Zou, MD, PhD; Hiroyuki Takano, MD, PhD; Miho Mizukami, MD; Hiroshi Akazawa, MD; Yingjie Qin, MD; Haruhiro Toko, MD; Masaya Sakamoto, MD; Tohru Minamino, MD, PhD; Toshio Nagai, MD, PhD; Issei Komuro, MD, PhD Background—Myocardial infarction (MI) is a leading cause of cardiac morbidity and mortality in many countries; however, the treatment of MI is still limited. Methods and Results—We demonstrate a novel gene therapy for MI using leukemia inhibitory factor (LIF) cDNA. We injected LIF plasmid DNA into the thigh muscle of mice immediately after inducing MI. Intramuscular injection of LIF cDNA resulted in a marked increase in circulating LIF protein concentrations. Two weeks later, left ventricular remodeling, such as infarct extent and myocardial fibrosis, was markedly attenuated in the LIF cDNA–injected mice compared with vehicle-injected mice. More myocardium was preserved and cardiac function was better in the LIF-treated mice than in the vehicle-injected mice. Injection of LIF cDNA not only prevented the death of cardiomyocytes in the ischemic area but also induced neovascularization in the myocardium. Furthermore, LIF cDNA injection increased the number of cardiomyocytes in cell cycle and enhanced mobilization

Journal

Circulation – Wolters Kluwer Health

Published: Aug 1, 2003

There are no references for this article.